A methylenetetrahydrofolate reductase gene polymorphism in multiple sclerosis

Area of Science:

• Neuroimmunology
• Genetics
• Biochemistry

Background:

• Cellular methylation pathways are implicated in multiple sclerosis (MS) pathogenesis.
• The methylenetetrahydrofolate reductase (MTHFR) gene plays a crucial role in folate metabolism and methylation.
• A common MTHFR gene polymorphism is associated with reduced enzymatic function.

Purpose of the Study:

• To investigate the association between a specific MTHFR gene polymorphism and susceptibility to multiple sclerosis (MS).
• To determine if MTHFR genotype distribution differs between MS patients and healthy controls.

Main Methods:

• Genotyping of a biallelic MTHFR gene polymorphism in 150 MS patients and healthy controls.
• Analysis of allele and genotype frequencies.
• Subgroup analysis based on clinical MS form and HLA class II phenotype.

Main Results:

• The distribution of MTHFR alleles and genotypes was nearly identical in MS patients and healthy controls.
• No significant differences were observed in subgroup analyses.
• The MTHFR polymorphism does not appear to be a risk factor for MS.

Conclusions:

• The investigated MTHFR gene polymorphism is not associated with susceptibility to multiple sclerosis (MS).
• This finding suggests that MTHFR-mediated methylation pathways may not be a primary genetic factor in MS development.